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Summary: Free tryptophan in plasma was separated by centrifugation through an Amicon Ultrafiltration
membrane cone. The value obtained without control of pH was found to be lower than that obtained with
control of pH by an improved method (Hijikata et al. (1981) Anal. Biochem. 118, 10-16).
For determination of the total tryptophan concentration in the plasma, high performance liquid chromatogra-
phy (HPLC) was better than the method of Denckla Dewey s modified by Bloxam & Warren ((1974) Anal.
Biochem. 60, 621—625), s judged on the basis of sensitivity, recovery rate and coefficient of variance. The
total tryptophan concentration in the plasma determined by HPLC was lower than that determined by the
Bloxam & Warren method.
The total tryptophan concentration (t-Trp), free tryptophan concentration (f-Trp) and f-Trp/t-Trp ratio were
55.8 ± 10.2 μιηοΐ/ΐ, 11.6 ± 1.5 μίηοΐ/ΐ and 0.211 ± 0.03 (mean ± l SD) respectively, in healthy subjects
(co trols). No significant difference was observed between the values of controls and those of patients with
liver cirrhosis, hepatocellular carcinoma, liver cirrhosis with hepatocellular carcinoma and hepatic encephalo-
pathy of liver cirrhosis without bleeding. But in liver cirrhosis with bleeding, free tryptophan concentration
(f-Trp, 48.0 ± 23.3 μτηοΐ/ΐ, p < 0.001) and f-Trp/t-Trp ratio (0.645 ± 0.289, p < 0.001) were significantly
higher than those of controls. In fulminant hepatitis free tryptophan concentration, (f-Trp, 106.6 ± 79.9
μιηοΐ/ΐ, p < 0.02), and f-Trp/t-Trp ratio (0.973 ± 0.017, p < 0.001) were significantly higher than those of
controls, and free tryptophan concentration (f-Trp) and f-Trp/t-Trp ratio (p < 0.005) were significantly
higher than in liver cirrhosis with bleeding. In other words the increase of free tryptophan concentration in
plasma may be related to the bleeding, and in fulminant hepatitis the binding ability of free tryptophan to
albumin may decrease.
In the examined cases of liver cirrhosis, the correlation of the concentration of plasma tryptophan with those
of other amino acids and indicators of liver function was changed when hepatocellular carcinoma was also
present.
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Bestimmung des freien Tryptophan im Plasma und ihre klinische Anwendung
Zusammenfassung: Freies Tryptophan im Plasma wurde durch Zentrifugation durch einen Amicon Ultrafil-
trations-Membrankegel abgetrennt. Der ohne pH-Kontrolle erhaltene Wert war niedriger als der mit pH-
Kontrolle nach einer verbesserten Methode nach Hijikata ((1981) Anal. Biochem. 118, 10-16) erhaltene.
F r die Bestimmung des gesamten Tryptophan im Plasma war die Hochleistungsfl ssigchromatographie
(HPLC) besser geeignet als die Methode von Denckla Dewey, modifiziert von Bloxam & Warren ((1974)
Anal. Biochem. 60, 621-625). Dies wurde durch Untersuchung der Empfindlichkeit, der Wiederfindung und
der Pr zision festgestellt; das durch HPLC bestimmte gesamte Tryptophan im Plasma war niedriger als das
mit der Methode von Bloxam & Warren bestimmte.
Bei gesunden Kontrollpersonen betrug die Konzentration des gesamten Tryptophan (t-Trp) 55,8 ± 10,2
μπιοΐ/ΐ, die des freien Tryptophan (f-Trp) 11,6 ± 1,5 μπιοΐ/ΐ und das Verh ltnis beider (f-Trp/t-Trp) 0,211 ±
0,03 (χ ± s). Es bestand keine signifikante Differenz zwischen den Werten der gesunden Kontrollpersonen
und denen von Patienten mit Lebercirrhose, hepatozellul rem Carcinom, Lebercirrhose bei gleichzeitig be-
stehendem hepatozellul ren Carcinom und hepatischer Encephalopathie bei Lebercirrhose ohne Blutung. Bei
Lebercirrhose mit Blutung waren jedoch freies Tryptophan (48,0 ± 23,3 μιηοΐ/ΐ, p < 0,001) und f-Trp/t-Trp-
Quotient (0,645 ± 0,289, p < 0,001) signifikant h her als bei den Kontrollpersonen. Bei fulminanter Hepati-
tis waren freies Tryptophan (106,6 ± 79,9 μπιοΐ/ΐ, p < 0,02) und der f-Trp/t-Trp-Quotient (0,973 ± 0,017,
p < 0,01) signifikant h her als bei den Kontrollpersonen sowie signifikant h her (p < 0,005) als bei Lebercir-
rhose mit Blutung. Der Anstieg der Konzentration des freien Tryptophan im Plasma k nnte zur Blutung in
Beziehung stehen, und bei fulminanter Hepatitis k nnte die Bindungsf higkeit von Tryptophan an Albumin
verringert sein.
In den untersuchten F llen von Lebercirrhose waren die Korrelationen der Konzentration von Tryptophan im
Plasma mit denen der anderen Aminos uren und Indikatoren der Leberfunktion ver ndert, wenn gleichzeitig
ein hepatozellul res Carcinom vorlag.
Introduction
Although the pathogenesis of hepatic encephalo-
pathy in severe hepatic failure is not clearly under-
stood, 2-oxoglutaramate (2), ammonia (3), free fatty
acids (4—7), methylmercaptan (7) and other false
neurotransmitters (8—12) are reported to be causes
of hepatic coma.
Tryptophan, the precursor of the putative neuro-
transmitter and serotonin, are reported to be in-
volved in hepatic encephalopathy (13, 14). But the
plasma tryptophan concentration often fluctuates in
hepatic encephalopathy, and so it is difficult to de-
termine whether tryptophan is directly related to he-
patic encephalopathy.
Munro reported that in severe hepatic failure, the
concentration of branched chain amino acids de-
creased and that the competitive Inhibition of the
passage of tryptophan through the blood brain barri-
er by other amino acids was abolished, resulting in
increased tryptophan and serotonin concentrations
in the brain and production of encephalopathy (15).
Tryptophan is the only amino acid that is present in
the blood in two states, free and bound to albumin
(16) and free tryptophan is thought to pass through
blood brain barrier. However, a Standard method for
the determination of free tryptophan in the plasma
has not been established. Recently, we improved the
method for Separation of free, tryptophan in plasma
by centrifugation through Amicon ultrafiltration
cones (17).
In this method, it is important to control the pH dur-
ing centrifugation, in order to maintain the equilibri-
um between free and bound tryptophan. In previous
reports, the plasma tryptophan is assayed without se-
parating the tryptophan (16, 18—20), so that con-
taminants in the sample influence .the value for the
tryptophan concentration. Therefore, f rther appli-
cation of high performance liquid chromatography
(HPLC) is useful for the specific determination of
tryptophan in the plasma. In fact the total trypto-
phan concentration in the plasma of patients with
liver disease determined by the method of Denckla
Dewey s modified by Bloxam & Warren, in which
tryptophan is not separated (1), tended to be higher
than those determined by HPLC.
Recehtly, Beck & Hesselgren (21) also s ggested the
usef lness of HPLC for determination of trypto-
phan. But they obtained the free tryptophan fraction
by ultrafiltration under press re riot by centrifuga-
tion.
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In this work, we determined the plasma free trypto-
phan of patients with hepatic diseases by HPLC, af-
ter Separation of free tryptophan from bound trypto-
phan by our improved method (17), and found that
free tryptophan in plasma increased in patients with
a tendency to bleeding.
Materials and Methods
Pat ien ts s tudied
Studies were carried out on 60 subjects. They were divided into 7
groups, classified äs follows:
1) 10 healthy volunteers äs controls,
2) 17 biopsy-proven cirrhotics without hepatic encephalopathy
(liver cirrhosis),
3) 13 cirrhotics with hepatocellular carcinoma without hepatic
encephalopathy (liver cirrhosis -l- hepatocellular carcinoma) (10
proven by biopsy; 3 on the basis of medical history and clinical
picture),
4) 6 biopsy-proven cirrhotics in grade 2 or 3 hepatic encephalo-
pathy without bleeding tendency,
5) 6 cirrhotics with bleeding tendency without hepatic encephalo-
pathy (3 autopsy proven, 3 biopsy-proven, 5 cases with rupture of
oesophagus varices and l with intestinal bleeding),
6) 5 hepatocellular carcinoma (4 biopsy-proven, l by clinical pic-
ture),
7) 3 autopsy-proven fulminant hepatitis in grade 3 or 4 hepatic
encephalopathy (fulminant hepatitis)
The grade of encephalopathy was assessed according to the classi-
fication of Trey et al. (22). All controls and subjects with liver
cirrhosis, liver cirrhosis + hepatocellular carcinoma and hepato-
cellular carcinoma fasted overnight before sampling. For liver cir-
rhosis with encephalopathy but no bleeding tendency with manif-
ested hepatic encephalopathy samples were obtained before startr
ing special treatment for hepatic encephalopathy. With liver cir-
fhosis with bleeding tendency and fulminant hepatitis, samples
were collected äs soon äs possible after admission.
Collection of blood and preparation of plasma
Collection of blood and further procedures were performed basi-
cally äs described previously (17). Human blood was collected
from the antecubital vein into a heparinized (143 U/ml) tube and
centrifuged at 3000g for 10 min at room temperature (25 °C).
The plasma was then rapidly transferred to a test tube (10 x 120
mm glass tube) and sealed with parafilm. In order to dispel the air,
the parafilm was pierced twice with a pin and a mixture of 0.05
CÜ2 and 0.95 NZ gas introduced into the tube at a rate of about 60
ml/min for 10 seconds through one of the holes. Then, the pin-
holes were sealed äs rapidly äs possible by covering the tube with
another piece of parafilm to avoid the escape of CO? from plasma.
Ul t ra f i l t ra t ion by centrifugation of plasma
Fresh plasma prepared äs described above was incubated at 37 °C
for 5 min, then 0.5 ml was transferred to a CF^SO Centriflo mem-
brane cone (Amicon) (nominal molecular weight cut-off: 50000)
inserted into a centrifuge tube. We used CF-50 cones äs supplied,
without soaking them in water to rernove the glycerol plasticizer.
The cone was sealed with parafilm and the air in the cone was
displaced with 0.05 CÜ2 and 0.95 N2 gas. The tube was centri-
fuged for 30 secondls at 3000 g at 37 °C (±1 °C) using a thermostat
Kubota KR-700 centrifuge. The filtrate was then transferred to a
small tube by a micropipet with which the volume (several micro-
liters) was measured, sealed tightly with parafilm, and quickly fro-
zen (-90 °C) until assay. After removing the first filtrate the cone
was recentrifuged for 10 seconds at 3000 g and the second filtrate
was obtained äs above. Four further centrifugations were carried
out until six-filtrates were collected. Ultrafiltration of plasma
without control of pH was carried out äs above except that the
cone was not sealed with parafilm and was centrifuged at 1000g
instead of 3000 g.
Measurement of pH and pCOi in plasma d u r i n g cen-
t r i f u g a t i o n
We prepared six cones each containing 0.5 ml of plasma, and dis-
placed the air with 0.05 CO2 and 0.95 N2 gas. After centrifugation
for 30 seconds, one of the six samples was applied to an automatic
blood gas analyser System (Acid Base Laboratory ABL-2 operat-
ing, Radiometer Copenhagen) to determine the pH and pCO2.
The other samples in the cones were subjected to pH and pCC>2
measurements after further centrifugation for successive 10 se-
cond periods.
D e t e r m i n a t i o n of amino acid concen t ra t ions
Tryptophan and other amino acids were determined by HPLC äs
reported in our previous papers (17, 23). D,L-Norleucine was
used äs internal Standard. In the comparison study, the Bloxam
Warren method (1) for plasma tryptophan was also carried out.
Results
Effect of pH of plasma dur ing centr i fuga-
tion on the free t ryp tophan concen t ra t ion
Ultrafiltrate was prepared by centrifuging plasma in
the cones without pH control, or pH was controlled
by filling the cones with 0.05 CO2 and 0.95 N2 gas
and sealing them with parafilm. The rates of filtra-
tion at 1000g without control of pH and at 3000g
with control of pH were similar.
As shown in figure l, the value for tryptophan con-
centration in the filtrate with pH control was always
higher than without pH control at the same total vo-
lume pf filtrate. Next we examined whether the pH
or pCC>2 of plasma in the cone influenced the trypto-
phan value in the filtrate (fig. 2). In plasma centrif-
uged äs described above with CO2 in N2 in place of
air, the plasma pH scarcely changed, whereas on fil-
tration without pH control, the pH increased and the
pCO2 decreased.
If we define free tryptophan of plasma äs the trypto-
phan concentratiön in the first filtrate by our method
with pH control (17), then the free tryptophan of
plasma of one healthy subject was 14.6 / ,
whereas the free tryptophan of the same subject was
5.4 / When the ultrafiltrate was obtained by
centrifugation of plasma for 20 min at 800 g without
pH control (16* 18-20) (data not shown).
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Fig. 1. Change of tryptophan concentration in the filtrate during
centrifugation of plasma in a cone with and without pH
control.
For pH control (solid line), after incubation for 5 min at
37 °C, 0.5 ml of plasma was transferred to a CF-50 Centri-
flo membrane cone (Amicon) inserted into a centrifuge
tube. The cone was seaied with parafilm and the air in the
cone was displaced with 0.05% C 2 and 0.95 N? gas s
described under materials and methods. The cone was
centrifuged at 3000 g for 30 seconds at 37 °C and then all
the filtrate was promptly transferred to a small test tube
using a micropipet with which the volume was measured.
The tube was seaied tightly with parafilm and stored at
—90 °C until assay. Samples obtained in the same way by 5
subsequent centrifugation s for 10 second periods were al-
so assayed. Without pH control (broken line), 0.5 ml of
plasma was transferred to a cone and centrifuged without
parafilm at 1000g at 37 °C. Other procedures were s
with pH control. Standard deviations of the volume of fil-
trate and observed tryptophan concentration in four dif-
ferent experiments on the same specimen of normal plas-
ma are shown by horizontal and vertical bars, respectively.
The tryptophan concentration of each fraction is plotted
against the cumulative volume of filtrate.
Comparison of the HPLC and Bloxam War-
ren methods for plasma tryptophan deter-
minat ion
Recovery rate
Samples of 0.9 ml of plasma containing ca. 30 μιηοΐ/ΐ
tryptophan were mixed with 0.1 ml of 50 μιηοΙ/1 or
200 μιηοΐ/ΐ tryptophan solution and the tryptophan
concentrations of the mixtures were determined by
HPLC and the Bloxam Warren method (1) (tab. 1).
By HPLC, the observed val es coincided with the
calculated val es, but by the Bloxam Warren meth-
od, val es were higher than expected, especially at
the lower concentration of tryptophan.
- 7.0
20 40
Volume of f i l t rate
60
Fig. 2. Changes of pH and pCC>2 of plasma in the cone during
centrifugation with and without pH control. The same
plasma s for fig. l was used after incubation for 10 min.
(No significant difference was observed between the plas^
ma samples at the beginning of the experiments in fig. l
and fig. 2.). The plasma was transferred to 12 cones (6
cones with, and 6 without pH control) in two centrifuges.
Centrifugation was carried out s for fig. l and the plasma
in each cone was used to measure the pH (A) and pCCh
(·). Val es with ( - - · . ) and without (- ?) pH control
are shown.
Tab. 1. Comparison of recovery rates of tryptophan in the HPLC
and Bloxam Warren method.
Samples of 0.9 ml of plasma containing ca. 30 μιηοΐ/ΐ
tryptophan were mixed with 0.1 ml of 50 umol/l (A) or
200 umol/l (B) tryptophan solution and the tryptophan
concentration was determined by the HPLC and Bloxam
Warren method. I and II are different plasmas. Val es are
recovery rates (%) of added tryptophan.
HPLC
A B
Bloxam Warren
A B
Recovery rate (%) III
98
103
100
100
180 130
270 140
Coefficient of Variation (CV)
The CV was smaller by HPLC (0.82%, n = 10) than
by the Bloxam Warren method (1.75%, n = 10) (da-
ta not shown), '*
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Effect of coexistent amino acids on tryptophan deter-
mination
As shown in table 2, two kinds of amino acid mix-
tures, one similar in composition to that in normal
plasma (A) and the other similar to that in liver dis-
ease (B), were prepared and their tryptophan con-
centrations were determined by HPLC and the Blox-
am Warren method. HPLC gave almost the expected
values, but the Bloxam Warren method did not.
Tab. 2. Comparison of values for tryptophan concentrations of
two amino acid mixtures measured by the HPLC and
Bloxam Warren method.
Two amino acid mixtures, one with the amino acid com-
position of normal plasma (A) and the other with that of
plasma in liver disease (B), were prepared and their tryp-
tophan concentrations were determined by the HPLC
and Bloxam Warren method.
A: Trp 10, Val 200, Met 50, He 50, Leu 100, Tyr 50, Phe
50 μιηοΙ/1.
B: Trp 46, Val 200, Met 70, Ile 40, Leu 100, Tyr 180,
Phe 100 μπιοΐ/ΐ.
Tryptophan concentration
observed in (μΐηοΐ/ΐ)
A B
HPLC 10.0 ±0.1 45.9 ±0.3
Bloxam Warren 8.0 ± 0.8 65.4 ± 1 .2
Comparison of the total tryptophan in patients mea-
sured by HPLC and the Bloxam Warren method
In all samples tested, values by the Bloxam Warren
method were higher than those by HPLC. They were
especially high in cases of fulminant hepatitis
(tab. 3).
1
 Tab. 3. Comparison of total tryptophan in plasma of cases of liver
diseases by HPLC and Bloxam Warren method.
Diagnosis Total tryptophan observed
(μιηοΐ/ΐ)
HPLC Bloxam Warren
Coritrol, healthy subjeCt 37.1 44.5
Hepatocellular carcinoma 24.6 30.2
Fulminant hepatitis 53-3 76.1
Fulminant hepatitis 27.0 ,31.4
Liver cirrhosis 74.1 89.6
Acute hepatitis (acute type) 60.6 64.6
Total tryptophan (t-Trp), free tryptophan (f+Trp) and
f -Trp/ t-Trp ratio in plasma of patients with various
liver diseases
Next we determined the ratio f-Trp/t-Trp, which is
especially high in severe cases of liver diseases, using
the total and free tryptophan for reference. Table 4
shows the values for total tryptophan (t-Trp), free
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tryptophan (f-Trp) and f-Trp/t-Trp ratio in the plas-
ma of cases of various liver diseases determined by
ultrafiltration-HPLC The values for cases' of liver
cirrhosis, liver cirrhosis -l· hepatocellular carcinoma,
liver cirrhosis with encephalopathy but no bleeding
tendency and hepatocellular carcinoma were not sig-
nificantly different from the control values. But in
cases of liver cirrhosis with bleeding tendency, free
tryptophan and f-Trp/t-Trp, values were significant-
ly higher than those of the controls (p < 0.01).
In 3 cases of fulminant hepatitis total tryptophan
varied greatly, being 215.2,109.6 and 11.3 μπιοΙ/Ί in
spite of comparatively similar values for the albumin
concentrations (30, 36 and 26 g/l respectively). It is
interesting that the f-Trp/t-Trp were 0.960, 0.932
and 0.972, indicating that almost all the tryptophan
was in the free state even at very low concentrations
of total tryptophan. Our results provided no Infor-
mation on the relation between free fatty acids and
free tryptophari,'because the free fatty acids concen-
tration was determined in only the first case (1120
μπιοΙ/1).
For reference purposes, the values for albumin, free
fatty acids, free tryptophan and total tryptophan in
cases of various liver diseases (n = 9) were examined
for possible correlations. Only free fatty acids and
albumin showed a significant relationship (r =
- 0.861, p < 0.01) (fig. 3): no relationship was ob-
served between free fatty acids and free or total tryp-
tophan (data not shown). Since the values for free
tryptophan and f-Trp/t-Trp ratio in cases of fulmi-
nant hepatitis (all of which showed a tendency for
bleeding), were significantly higher than those in liv-
er cirrhosis with bleeding tendency (p < 0.005), the
binding ability of albumin to free tryptophan might
be changed in fulminant hepatitis.
Relationship between plasma tryptophan and indica-
tors of liver function in plasma, or between plasma
tryptophan and plasma free amino acids other than
tryptophan
In some examples, involving a significant number of
cases the relationship was tested in detail (tab. 5).
Close correlation was observed between total and
free tryptophan in liver cirrhosis but not in liver cir-
rhosis + hepatocellular carcinoma. On the other
hand, free tryptophan and f-Trp/t-Trp were closely
related in both liver cirrhosis and liver cirrhosis +
hepatocellular carcinoma. It is interesting that the
correlation between alkaline phosphatase and free
tryptophan or f-Trp/t-Trp ratio increased when liver
cirrhosis was combined with hepatocellular carcino-
ma.
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Fig. 3. Relationship between free fatty aeids and albumin in plas-
ma of patients with liver diseases.
O liver cirrhosis, Δ liver cirrhosis coma, © liver cirrhosis
varix*, O liver cirrhosis + hepatocellular carcinoma, χ ful-
minant hepatitis. ·
Significant relations were not observed between free fatty
acids and free or total tryptophan and between albumin
and free or total tryptophan. *: case of rupture of oesopha^
gus varix in livef cirrhosis. r = -0.861; p < 0.01.
Discussion
Many studies have been reported (18, 24—26) on
the Separation of free tryptophan from plasma, but
the results were not satisf ctory beca se equilibrium
between free tryptophan and bound tryptophan
changed d ring Separation of the free tryptophan
fraction.
Ultrafiltration of plasma in Amicon membrane
cones with control of pH was successful and conve-
nient for obtaining the free tryptophan fraction^ and
this method in combination with HPLC was better
for determination Of free tryptophan than any meth-
od reported already (16, 18—20). In this work we
examined the effect of pH of plasma d ring centrifu-
gation on the free tryptophan concentration of the
filtrate. Without control of pH d ring centrifugation,
the plasma pCO2 in the cone decreases *and the plas-
ma pH gradually increases. When the cone was filled
with 0.05 CO2 and 0.95 N2 gas, the pCO2 and pH
remained almost constant and the observed free
tryptophan concentration in the filtrate was higher
than that witho t pH control.
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Tab. 5. Relationships of plasma tryptophan concentrations with indicators of liver function and plasma amino acid concentrations.
Free tryptophan (f-Trp)
f-Trp
t-Trp
Total amino acidsa)
Isoieucine
Methionine
Tyrosine
Phenylalanine
Lysine
Citrulline
Glycine
Alanine
Cysteine
Taurine
Serine
Histidine
Ornithine
Arginine
Aspartatc aminotransferase
Lactate dehydrogenase
Leucine aminopeptidase
Alkaline phosphatase
Total bilirubin
Prothrombin time
Thrombocytes
Choline esterase
Total protein
Albumin
Total cholesterol
Branched/aromatic amino acidsb)
Albumin/globulin ratio
Liver cirrhosis Liver cirrhosis Hepatocellular carcinoma
+ hepatocellular carcinoma
(Π) (13) (5)
t-Tro f-Tro f"TrP t-Tro f-Tro f"Trp t-Tro f Tro f"TrpTrp tT p
 t_Trp  i p t I p ^ t- p f- rp ^
0.602""
0.760"" 0.954""
0.493*
0.526"'
-0.581"
-0.415* 0.701"* 0.766*" 0.910*
-0.541*
0.585" 0.965'"
0.471*
0.486*
0.817* 0.886*
-0.632*"
0.562" 0.576" -0.858*
0.509* -0.414* 0.639" 0.666" 0.932**
0.578" 0.526* 0.521*
0.627*"
0.942*"
0.665" 0.911"
-0.572** 0.549* 0.687"* -0.842*
-0.611"* 0.575* 0.855*
0.746"* 0.82 Γ"*
0.542* -0.553*
0.551* 0.558*
-0.542*
0.593" -0.582*
-0.528* -0.481* 0.846*
0.630*** 0.637***
-0.457* 0.626*" 0.641" 0.604* 0.908" 0.811*
0.536*
0.500* 0.488**
Only significant values are shown. With indocyanine green test, esterified/total cholesterol, total tryptophan, valine, leucine, glutamic
acid and alanine aminotransferase, no significant difference was observed. " p < 0.05, " p < 0.02 "* p < 0.01 *"** p < 0.005 a)
mol/1 b) mol fraction.
Bloxarrfs method (27) for free tryptophan determi-
nati n needs special apparatus and is inconvenient.
But in our method, only displacement of the air by
C 2 in N2 gas is necessary to keep the plasma pH
and pCO2 constant. Moreover we could obtaifi a
sample by centrifugatipn at 3000 g for 30 seconds,
the minimum volume required was 5 μΐ, and trypto-
phan separated by HPLC could be measured without
interference frorii other components in the plasma.
Thus by ouf method, a sample closely approximating
to that of free tryptophan in the plasma can be ob-
tained in a short time.
The Bloxam Warren method of tryptophan determi-
nation gives an incorrect recovery, a higher CV than
HPLC and an inaccurate value; this is because the
tryptophan is not fractionated so that other amino
acids and their derivatives that influence the value
are present in the sample. No significant differences
were found in the values of plasma total tryptophan,
free tryptophan and f-Trp/t-Trp ratio in patients
with liver cirrhosis, liver cirrhosis + hepatocellular
carcinoma, hepatocellular carcinoma and liver cir-
rhosis with encephalopathy but no bleeding tenden-
cy compared with healthy controls. There are reports
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that plasma free tryptophan is significantly higher in
liver cirrhosis (28), or hepatic encephalopathy of liv-
er cirrhosis than in healthy controls (19, 29—31).
These values were obtained, however, by measuring
the tryptophan concentration in the filtrate after
centrifugation without pH control, and without Sepa-
ration of tryptophan from other amino acids and
components related to tryptophan which might influ-
ence the fluorescence assay of tryptophan. The fact
that free tryptophan and f-Trp/t-Trp ratio were
found to be significantly raised in cases of liver cir-
rhosis with bleeding tendency might be due to reab-
sorption of blood from the alimentary tract.
Our results do not necessarily show that bleeding en-
hances the free tryptophan in the plasma, because
we examined too few cases. However, the finding by
Ono et al. (19) of high free tryptophan in hepatic
encephalopathy of liver cirrhosis suggests that hepat-
ic encephalopaihy of liver cirrhosis in their case
might be accompanied by bleeding.
The tryptophan concentration in the cerebrospinal
fluid (CSF) of cases with hepatic encephalopathy
was reported to be significantly higher than that in
cases without encephalopathy (19). This increase
was believed to be caused by an increase of free tryp-
tophan in the plasma. But our study showed that the
plasma tryptophan concentration in liver cirrhosis
with encephalopathy but no bleeding tendency was
similar to that of controls. Our data are compatible
with the fact that a raised value of tryptophan in the
CSF is independent of the plasma free tryptophan,
because the permeability of the blood brain barrier
changes in hepatic encephalopathy (32, 33). From
extensive studies, Mans et al. (32) concluded that the
influx of tryptophan through the blood brain barrier
changes with the concentration and composition of
competing amino acids; in other words, even when
the plasma free tryptophan is not high enough to
evoke encephalopathy, prolonged slight encephalo-
pathy may promote the passage of tryptophan
through the blood brain barrier into the brain and
result in encephalopathy by tryptophan itself. If this
is the case, transfusion of excess branched chain ami-
no acids may repress the transport of tryptophan into
the brain and be helpful in treatment of encephalo-
pathy. In fact very low tryptophan concentrations in
plasma were observed in some hepatic encephalo-
pathy (data not shown).
Hutson et al. (20) reported that after recovery from
coma plasma free tryptophan decreased but trypto^
phan in the CSF remained unchanged. The decrease
of plasma free tryptophan may be the result of ini-
provement of liver function, and this improvement
may decrease the concentrations of substances that
evoke coma to values below those effective in pro-
ducing coma. The substances producing coma are re-
ported to be 2-oxoglutaramate (2), ammonia (3),
free fatty acids (4—7), methylinercaptan (7) and oth-
er false neurotransmitters (8—12); these compo-
nents also act synergistically. We plan to study the
effects of amino acid metabolism, mercaptan, am-
monia and false transmitters and their mutual rela-
tions on the mechanism of the blood brain barrier.
In fluminant hepatitis, whether the total tryptophan
is low or high, almost all the tryptophan is free.
Since, äs far äs examined, free fatty acids had no re-
lation with free tryptophan, the binding ability of
tryptophan to albumin may change in fulminant he-
patitis. In this decrease, though there is some tend-
ency for bleeding, f-Trp/t-Trp ratio is significantly
higher than in liver cirrhosis with bleeding, suggest-
ing that the conditions are different from those in
liver cirrhosis with bleeding tendency. The relation
between bleeding and tryptophan or f-Trp/t-Trp ra-
tio must be examined in more cases.
As shown in table 5, positive relations of free and
total tryptophan to albumin were found in liver cir-
rhosis, but not in liver cirrhosis with hepatocellular
carcinoma. Moreover many correlations of trypto-
phan with amino acids, and of Syptophan with liver
function, were found to be changed in liver cirrhosis
when hepatocellular carcinoma was present. These
results indicate that liver disease involves changes in
metabolism and liver function, which are responsible
for the observed changes in the relation between
tryptophan and other amino acids, and between
tryptophan and liver function. These results indicate
that liver disease involves changes in metabolism and
liver function, which are responsible for the ob-
served changes in the rejationship between trypto-
phan and other amine acids, and between trypto-
phan and liver function.
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